H

Hyphens Pharma International Ltd
SGX:1J5

Watchlist Manager
Hyphens Pharma International Ltd
SGX:1J5
Watchlist
Price: 0.285 SGD
Market Cap: 88.1m SGD
Have any thoughts about
Hyphens Pharma International Ltd?
Write Note

Relative Value

The Relative Value of one 1J5 stock under the Base Case scenario is 0.557 SGD. Compared to the current market price of 0.285 SGD, Hyphens Pharma International Ltd is Undervalued by 49%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

1J5 Relative Value
Base Case
0.557 SGD
Undervaluation 49%
Relative Value
Price
H
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
83
Median 3Y
0.6
Median 5Y
0.6
Industry
2.6
Forward
0.4
vs History
85
vs Industry
36
Median 3Y
9.9
Median 5Y
10.3
Industry
23
Forward
7.5
vs History
0
vs Industry
27
Median 3Y
12.4
Median 5Y
12.6
Industry
17.8
vs History
vs Industry
12
Median 3Y
10.9
Median 5Y
11.5
Industry
25.4
vs History
63
vs Industry
52
Median 3Y
1.4
Median 5Y
1.4
Industry
2.2
vs History
69
vs Industry
88
Median 3Y
0.4
Median 5Y
0.4
Industry
2.8
Forward
0.4
vs History
49
vs Industry
81
Median 3Y
1.1
Median 5Y
1.1
Industry
5.4
vs History
73
vs Industry
46
Median 3Y
4.1
Median 5Y
4.3
Industry
13.7
Forward
4.3
vs History
74
vs Industry
43
Median 3Y
5
Median 5Y
5.3
Industry
17.2
Forward
4.9
vs History
0
vs Industry
34
Median 3Y
8.1
Median 5Y
8.3
Industry
16.5
vs History
0
vs Industry
24
Median 3Y
9.2
Median 5Y
9.6
Industry
19.3
vs History
88
vs Industry
51
Median 3Y
1.3
Median 5Y
1.5
Industry
2

Multiples Across Competitors

1J5 Competitors Multiples
Hyphens Pharma International Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SG
Hyphens Pharma International Ltd
SGX:1J5
88m SGD 0.5 8.5 3.7 4.3
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
777.8B USD 19 92.9 49.9 55.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.2 34.9 24.3 27.7
US
Johnson & Johnson
NYSE:JNJ
367.4B USD 4.2 25 12.1 15.7
US
Merck & Co Inc
NYSE:MRK
249.6B USD 4 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.3B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
180.7B CHF 4.2 12.7 10 14.9
UK
AstraZeneca PLC
LSE:AZN
154.9B GBP 4 30.7 169 253.3
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6

See Also

Discover More
Back to Top